HUTCHMED (China) (HCM) Cash & Current Investments (2014 - 2025)

HUTCHMED (China)'s (HCM) quarterly Cash & Current Investments came in at $175.8 million in Q4 2025, down 100.0% year-on-year from $107549.6 billion in Q4 2024, and down 87.12% on a QoQ basis from $1.4 billion in Q2 2025.

HUTCHMED (China) (HCM) Cash & Current Investments (2014 - 2025) Analysis & Trends

HUTCHMED (China) (HCM) has 12 years of Cash & Current Investments data on file, last reported at $175.8 million in Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 100.0% year-over-year to $175.8 million in Q4 2025; TTM through Dec 2025 was $175.8 million, a 100.0% decrease from a year earlier, with the FY2025 full-year figure at $175.8 million, down 100.0% from the prior year.
  • Cash & Current Investments for Q4 2025 stood at $175.8 million, down from $1.4 billion in the prior quarter.
  • Over the last five years, Cash & Current Investments for HCM reached as high as $107549.6 billion in Q4 2024 and fell as low as $113433.7 in Q4 2023.
  • Historically, Cash & Current Investments has averaged $9777.7 billion across 5 years, with a median of $802.5 million in 2024.
  • Across the five-year window, Cash & Current Investments surged 94812718875.99% in 2024 and sank 100.0% in 2025, its largest moves.
  • Year by year, Cash & Current Investments stood at $129.9 million in 2021, then plunged by 37.89% to $80.7 million in 2022, then plunged by 99.86% to $113433.7 in 2023, then surged by 94812718875.99% to $107549.6 billion in 2024, then sank by 100.0% to $175.8 million in 2025.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $175.8 million in Q4 2025, $1.4 billion in Q2 2025, and $107549.6 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.69 Bn 87.82 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.57 Bn 30.63 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.52 Bn 23.46 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 23.08 Bn 20.93 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 22.43 Bn 22.43 Bn - -
7 Viatris 20.23 Bn 18.42 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.78 Bn 16.46 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.61 Bn 12.18 Bn 785.00 Mn 428.00 Mn
10 HUTCHMED (China) 9.57 Bn 9.39 Bn - 175.80 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 175.80 Mn
Jun 30, 2025 1.36 Bn
Dec 31, 2024 107,549.61 Bn
Jun 30, 2024 802.45 Mn
Dec 31, 2023 113,433.74
Jun 30, 2023 856.17 Mn
Dec 31, 2022 80.67 Mn
Jun 30, 2022 826.20 Mn
Dec 31, 2021 129.88 Mn
Jun 30, 2021 950.45 Mn
Mar 31, 2021 396.07 Mn
Dec 31, 2020 435.18 Mn
Jun 30, 2020 281.01 Mn
Dec 31, 2019 217.17 Mn
Sep 30, 2019 201.58 Mn
Jun 30, 2019 237.29 Mn
Mar 31, 2019 271.86 Mn
Dec 31, 2018 300.95 Mn
Jun 30, 2018 322.49 Mn
Dec 31, 2017 358.30 Mn